EladSharonMD

PubMed

• A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers.
  Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel, Robert Edwards, Jennifer M Scalici
  Clinical Cancer Research. 2025-01-17
• A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer.
  Randy F Sweis, Gurkamal S Chatta, Rohit K Jain, Helen Moon, Scott Edward Delacroix
  Clinical Cancer Research. 2025-01-17
• Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.
  Jyoti Mayadev, Dmitriy Zamarin, Wei Deng, Heather A Lankes, Giulio Pesci
  Nature Communications. 2025-01-09

Journal Articles

• Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 Study  
  Michael S Khodadoust, Pierluigi Porcu, Francine Foss, Andrei R Shustov, Satish Shanbhag, Lubomir Sokol, Steven M Horwitz, Elad Sharon, European Journal of Cancer
• Immuno-Oncology Trial Endpoints: Capturing Clinically Meaningful Activity  
  Elad Sharon, Patrick M Forde, Valsamo Anagnostou, Hao Wang, Franco Verde, Mark Yarchoan, Clinical Cancer Research
• From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely  
  Arta M Monjazeb, Elad Sharon, Clinical Cancer Research

Abstracts/Posters

• Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
  Elad Sharon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019